The OPAL 2 Study
The OPAL 2 Study
This research study will compare the experience of using an Omnipod 5 pod pump to ‘usual care’ in people living with type 1 diabetes.
Participants will be randomly assigned to use the Omnipod 5 or their usual diabetes care method for approximately 6 months. If you are assigned to the usual care group, you will have the option to use the Omnipod 5 for approximately 3 months after completing the study.
Participation in this study will involve:
- 26 weeks participation
- 13 on-site and/or online clinic visits
- Wearing a CGM +/- the Omnipod 5 Patch Pump
This trial is also recruiting participants for a regional satellite site in Wangaratta.
The OPAL 2 Study
The OPAL 2 Study
This research study will compare the experience of using an Omnipod 5 pod pump to ‘usual care’ in people living with type 1 diabetes.
Participants will be randomly assigned to use the Omnipod 5 or their usual diabetes care method for approximately 6 months. If you are assigned to the usual care group, you will have the option to use the Omnipod 5 for approximately 3 months after completing the study.
Participation in this study will involve:
- 26 weeks participation
- 13 on-site and/or online clinic visits
- Wearing a CGM +/- the Omnipod 5 Patch Pump
This trial is also recruiting participants for a regional satellite site in Wangaratta.